A Structuralised Sick-leave Program Compared to Usual Care Sick Leave Management in Patients After an Acute Myocardial Infarction
|ClinicalTrials.gov Identifier: NCT01108653|
Recruitment Status : Unknown
Verified January 2010 by Oslo University Hospital.
Recruitment status was: Recruiting
First Posted : April 22, 2010
Last Update Posted : May 7, 2010
|Condition or disease||Intervention/treatment||Phase|
|Myocardial Infarction||Other: Usual care sick-leave management Other: Structuralised sick-leave program||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||120 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Health Services Research|
|Official Title:||A Structuralised Sick-leave Program Compared to Usual Care Sick Leave Management in Patients After an Acute Myocardial Infarction|
|Study Start Date :||January 2010|
|Estimated Primary Completion Date :||December 2012|
|Estimated Study Completion Date :||December 2012|
|Group 1: Usual care sick-leave management||
Other: Usual care sick-leave management
Patients randomized to usual care. Follow up after discharge by general practitioner (GP) according to local practice.
|Group 2: Structuralised sick-leave program||
Other: Structuralised sick-leave program
Patients randomized to the structuralized program will get full time sick-leave for 2 weeks after discharge.Cardiologist will be responsible for individual adaption of each patient`s sick-leave and follow-up.
- Cost effectiveness [ Time Frame: one year ]In order to evaluate resource use (costs) all patients will be asked to fill in a questionnaire at baseline and after 6 and 12 months. Total costs and mean costs will be calculated in the two different follow-up modalities.
- Quality of Life measures are estimated at baseline and after 6 and 12 months using the standard Medical Outcomes Study Short form( SF-36)questionnaire and the disease-specific Utility-Based Quality of life-Heart questionnaire(UBQ-H). [ Time Frame: one year ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01108653
|Contact: Stefan Agewall, Professor, MD.PhDfirstname.lastname@example.org|
|Contact: Liv Mundal, MDemail@example.com|
|Oslo University Hospital||Recruiting|
|Oslo, Trondheimsveien 235, Norway, 0514|
|Principal Investigator: Stefan Agewall, Professor|
|Principal Investigator:||Stefan Agewall, Professor||Oslo University Hospital. Department of Cardiology. Trondheimsveien 235, 0514 Oslo, Norway|